by Rod Raynovich | Nov 30, 2010 | 2023-24 Life Science Portfolios, BIOgraph
Gen-Probe (GPRO,$51.60) announced yesterday that it submitted a Premarket Approval Application(PMA) the the FDA for its APTIMA HPV (human papillomavirus ) assay , a molecular diagnostic test that detects high-risk HPV infections that are associated with cervical...